{
"papers": [
{
"n": 0,
"doi": "10.1007/s11689-009-9023-x",
"value": "reduced PV cells with asymmetric hemispheric distribution",
"method": "immunohistochemistry PV cell counting",
"metric": "PV cell count in neocortex",
"n_analyzed": 0,
"ci_or_error": null,
"text_access": "fulltext",
"n_definition": "mice per genotype",
"scope_region": "neocortex (parietal and occipital)",
"study_system": "VPA and NL-3 R451C ASD mouse models",
"taxonomic_level": "single cell type (PV neurons)",
"scope_population": "PV-positive interneurons",
"value_source_sentence": "PV-cells were reduced in the neocortex across multiple ASD mouse models.",
"experimental_conditions": "ASD models vs controls"
},
{
"n": 0,
"doi": "10.1523/jneurosci.5419-08.2009",
"value": "decreased density in mPFC and ventral hippocampus",
"method": "immunohistochemistry with stereological counting",
"metric": "PV interneuron density in mPFC",
"n_analyzed": 0,
"ci_or_error": null,
"text_access": "abstract_only",
"n_definition": "rats per group",
"scope_region": "mPFC and ventral hippocampus",
"study_system": "MAM rat model of schizophrenia",
"taxonomic_level": "single cell type (PV neurons)",
"scope_population": "PV-positive interneurons",
"value_source_sentence": "MAM-treated rats display a decreased density of parvalbumin-positive interneurons throughout the medial prefrontal cortex (mPFC) and ventral (but not dorsal) subiculum of the hippocampus.",
"experimental_conditions": "MAM vs saline treated"
},
{
"n": 0,
"doi": "10.1038/nn.2447",
"value": "reduced PV expression in NMDAR-ablated interneurons",
"method": "immunohistochemistry, western blot",
"metric": "PV protein expression in cortex",
"n_analyzed": 0,
"ci_or_error": null,
"text_access": "fulltext",
"n_definition": "mice per genotype",
"scope_region": "cortex and hippocampus",
"study_system": "NR1 deletion in corticolimbic interneurons (schizophrenia model)",
"taxonomic_level": "interneuron subtype (PV-expressing)",
"scope_population": "corticolimbic interneurons",
"value_source_sentence": "Reduced expression of glutamic acid decarboxylase 67 and parvalbumin was accompanied by disinhibition of cortical excitatory neurons and reduced neuronal synchrony.",
"experimental_conditions": "conditional knockout vs control"
}
],
"comparison_id": "pv-cell-reduction-across-psychiatric-mouse-models",
"comparison_name": "PV cell reduction across psychiatric disorder mouse models",
"comparison_type": "convergent evidence",
"what_it_reveals": "PV cell reduction is a convergent phenotype across ASD, schizophrenia, and NMDAR hypofunction models, supporting PV circuits as a shared vulnerability across neurodevelopmental disorders",
"homogeneity_check": {
"caveats": [
"Different brain regions examined: neocortex vs mPFC vs cortex+hippocampus",
"Different species: mouse vs rat",
"Different disease models with different etiologies",
"Measurements are qualitative (decreased) without standardized effect sizes"
],
"n_definition_uniform": "false",
"scope_region_uniform": "false",
"taxonomic_level_uniform": "true",
"scope_population_uniform": "true"
},
"suggested_plot_type": "forest plot"
}